Abstract
Introduction
In Multicentre Studies the collection, organization and statistical analysis of studydata requires a sophisticated information support system. An ideal system should be easy accessible and should provide high security. For this reason Web-based or Web-enabled Remote-Data-Entry is seen as the most promising technology. This way of Data Management is ideal for data entry from distributed locations that have little or no computer infrastructure.
Authors' experience and objective
In the field of Data Collection for Clinical Trials the Authors have experience with OPEN-Source engineered products set up in a LAMP andlor PHP and ODBC environment [I] , have used the PhOSCom [21 Platform and have used professional tools (Oracle Clinical@, SAS@ and Business Objects@) [3] .
The objective of this work was to develop a Scorecard for the evaluation of any Clinical Trial Setting to determine which Software and Strategy to choose. For this target to achieve, especially the experience from the use of the Oracle Clinical@ 4 / SAS@ 8.2 and the use of the PhOSCom Platform where compared and discussed.
2.
Actual situation: market shares For the generation of the Scorecard the Keypoints from known projects [I] 121 [3] were collected and put in relation to the common variables of a clinical trial.
Additionally the parameters of the Companies ITStrategy and IT Environment were put into equation for the scorecard. The resulting Questions were clustered into groups to determine a score for each single Keypoint and determine a score fur the best recommendation.
3.

Identification of key criteria
The following Criteria were identified to be crucial in Setup of a Clinical Trial Data Management Environment:
Process scalability and flexibility
Depending on the Trial's scale and potential diversity of future 'Ilials a Remote-Data-Entry solution should be more or less open from a process-oriented point of view. To identify the individual requirements, questions for Trial Settings with rapid changing requirements were clustered. For those it is crucial to be able to accommodate the software in different ways: fast performing tasks inhouse, easy working with partners, cooperation with other entitities (academia or other P h m a ) or any other model representing any combination. In this point Open-Source Software seems to have a clear advantage 14).
Technology integration
From a technology point of view the scalability and flexibility has to be seen more from the GUI, the database end and the intercomponent communications.
The decision, which software to choose depends on a variety of factors of the in-house IT-infrastructure. How big is the amount of data being managed, what flexibility is needed in database-interconnectivity and in database- 
Rollout process
A simple and easy rollout process seems to be crucial -adequate to trial dimension and complexity. For the Scorecard a Cluster of Questions was setup to determine those variables.
While the environment must be validatable, all other factors can't be bought at the expense of the need for a complex or lengthy installation process. In the actual PhOSCoTM V1.3 specially Installation Process and GUI are not ideal for less complex Data Entry Scenarios, where for example a normal javascripted webfrontend (also from FDAs view) is enough.
In a capsulated standard Clinical Trial Environment
with data from very distributed locations benefits and savings from Database-and Softwarelicenses can be overweighted by costs for installations and distributions of -for example -preinstalled laptops.
CRF-to-bedside time
A crucial factor in fast-pacing Trial Environments is the easy internalisation of the development of eCRFs and shortest possible time to first patient visit, using existing clinical staff.
Depending 
Provider dependency
Avoiding a dependency on special companies seems to be a critical success factor in every project. The TradeOff having to do this is often the need for a special, capsulated, single and cheap solution and no local ITRessources. The danger of this dependency is in terms of risks regarding software delivery and future maintenance as well as the danger of limited capability to scale up to the requirements of the programme.
Especially for larger-scale trials international service partners must be readily available to complement the internal resources, and the business concept has to be open to allow the addition of further partners when required.
Liiecycle and version management
Depending on the Spectrum of Trials being managed and the IT-Strategy there are some remarkable advantages in the use of Open-Source Software. For example the need for a simple and preferably automated process for maintenance of trial customisation and the software itself during the lifecycle of a trial, together with the capability of normal business change control management.
The Questionaire includes for example questions on Importance of fast Internationalisation and multilingual capabilities.
Legal regulations
The Scorecard was put up with a special sequence of questions determining the need for special regulations regarding legal aspects and Software validation in a special Trial Setting. It turns out that the use of software under the regulations of the GNU [61 [7] has some specialities which can be a benefit or disadvantage for a company -a decision mostly basing on a general strategy to take back the ownership of a product back in house.
One mayor obstacle in Open-Source -the timeconsuming process of Software-Validation seems to k solved with PhOSCoTM, as the tools for automated validation give a wide perspective mostly not found in the available commercial products.
Discussion and results
How is actual Situation at Companies having to decide between the two different approaches? A trend is heading clearly to Open-Source Products being developed from a core-version to individual needs of a company.
O f course implementing such a system is a major challenge, according to Sylvia Collins, who did this for Novartis [8]. Strong leadership, change management and broad authority were required. Most importantly it needs to be pushed forward as a business development. not an IT development.
As described above based on the popular PhOSCoTM product, the system at Novartis is continually being developed. It is deployed on 3000 laptops worldwide and has been deployed on 150 trials within 18 months. Database licence savings alone have been over $50 million US Dollars [8]. The configuration and deployment of the clinical report forms takes around 9 weeks but Novartis hopes to improve this considerably.
The PhOSCom product is available for purchase, on a per trial or corporate basis, and is supplied with full lava source code for customisation and integration. With Open-Source Packages like PhOSCoTM even huge trials can be managed at low cast for software licenses. Overall choosing a professional environment makes trial control and management in points of standard integration and CRF-Design more mnvenient but also much more costly and not in every case more flexible.
Specially for Companies heading to a global OpenSource Strategy and/or having to keep Your Trial Software in a changing long-term hybrid communication model, PhOSCoTM seems a viable alternative.
